Mayfield Biotech at Disrupt 2021 - Innovation & Discovery

Addressing Global Health Challenges Through Innovation

The most significant undertaking for our time involves simultaneously improving both human and planetary well-being. This also represents an unprecedented opportunity for entrepreneurs. Consequently, we have collaborated with Mayfield to present an engineering biology track at Disrupt 2021, scheduled for September 21-23.

Have you registered yet? Secure your ticket now for $99 (or a reduced rate if you are a student, startup founder, or work for a nonprofit or government organization).

Mayfield's Extensive Experience

Mayfield brings over five decades of venture capital expertise, prioritizing investment in individuals with a focus on enterprise, consumer, and engineering biology ventures. Throughout their 50+ year history, they’ve been early backers of prominent biotech and health IT innovators – including Amgen, Genentech, and Mammoth Biosciences – all dedicated to fostering a better future.

Featured Speakers and Sessions

This dedicated track will showcase valuable perspectives from founders of companies valued in the billions, such as Twist Bioscience, Ginko Bioworks, and Adaptive Bio. It will also include insights from NotCo, a rising star in planetary health and an Indie Bio company, and Mammoth Biosciences, a pioneering CRISPR platform co-founded by Nobel laureate Jennifer Doudna.

Furthermore, the track features Mostafa Ronaghi, a leading SPAC manager and former CTO of Illumina, alongside other innovators tackling the interconnected challenges of human and planetary health.

Session Highlights

• Bioplatforms for Saving the Planet: Mayfield’s Arvind Gupta will be joined by Twist CEO Emily Leproust and Ginko Bioworks CEO Jason Kelly to discuss their entrepreneurial journeys, from initial concept to IPO and beyond, and their impact on the world.
• Saving Lives with Precision Biology: Ursheet Parikh from Mayfield will host a discussion with Mostafa Ronaghi (former CTO, Illumina), Chad Robins (co-founder & CEO, Adaptive Biotechnologies), Yan Zhang (CEO, Mission Bio), and Diego Rey (co-founder & CSO, Endpoint Health) on leveraging biological advancements to improve healthcare outcomes.
• Taking Care of the Next Generation: Kamini Ramani of Mayfield will engage with Sandra Oh Lin (KiwiCo), Maneesh Jain (Mirvie), and Stu Landesberg (Grove Collaborative) to explore building a better world for future generations, fostering communities, and achieving significant growth.
• The New Human and Planetary Health Pioneers: Arvind Gupta from Mayfield will converse with Trevor Martin (Mammoth Biosciences) and Matias Muchnick (NotCo) about the challenges and strategies for scaling innovative businesses.
• Rewiring the Brain to Improve the Quality of Life: Ursheet Parikh from Mayfield will lead a discussion with neuroscientists, physicians, and entrepreneurs – Nanea Reeves (TRIPP), Konstantinos Alataris (Nēsos), and Paul Dagum (Mindstrong Health) – on developing brain-based solutions to enhance well-being.

Consult the Disrupt 2021 agenda for specific session times based on your time zone.

Join the Conversation

TechCrunch Disrupt 2021 will be held from September 21-23. Whether you are a scientist or simply interested in innovation, don’t miss the sessions within this specialized engineering biotech track. Learn from visionary leaders committed to creating a more sustainable and healthy world.

Purchase your Disrupt 2021 pass today and participate in this compelling dialogue for under $99.